BioMérieux

Accelix is a biotechnology company that helps cell and gene therapy companies to meet their key product QC requirements. It provides an instrument and a room temperature stable cartridge to gather multi-parameter results. The company was founded in 2007 and headquartered in Yerushalayim, Israel.

At Invisible Sentinel, we develop first in class, next generation technologies for a safer food supply. As innovators in rapid diagnostics, we focus on the prevention of foodborne illnesses by developing leading-edge molecular and antigen detection technologies that quickly provide highly accurate information on the presence of harmful pathogens reducing time-consuming sample preparation. Uniquely designed for easy, practical use—on-site and throughout the entire food distribution network—our patented and AOAC approved Veriflow™ technology promises to create a new standard for rigorous quality control.

SuZhou Hybiome Biomedical Engineering Co.Ltd. engages in research, manufacturing, and sales of instruments and matching reagents for clinical immunological analysis and blood tests. Its products include automatic luminescence immunity analyzer with the matching immunoassay reagents and automatic blood grouping analyzer applicable for micro-column gel immunoassay. The company was founded in 2009 and is based in Suzhou, China. As of November 9, 2018, SuZhou Hybiome Biomedical Engineering Co.Ltd. operates as a subsidiary of bioMérieux S.A.

Astute Medical, Inc. is a life science tools company specializing in the discovery and development of protein biomarkers for rapid diagnosis and risk assessment of acute medical conditions. Founded in 2007 and based in San Diego, California, with a location in Paris, France, the company focuses on validating prognostic biomarkers related to conditions such as abdominal pain, acute coronary syndromes, cerebrovascular injury, kidney injury, and sepsis. Its primary product, NephroCheck, is a single-use cartridge designed to detect biomarkers of acute kidney injury, while the Astute140 meter converts the fluorescent signals from the NephroCheck cartridge into a single numerical result. Astute Medical's products are marketed in the United States and Europe and aim to enhance clinical decision-making and patient outcomes. As of April 2018, Astute Medical operates as a subsidiary of bioMérieux S.A.

Qvella Corporation is a Toronto-based molecular diagnostics company established in 2009 by a team of scientists and engineers. The company focuses on advancing sample preparation and detection technologies in clinical microbiology, aiming to significantly reduce the time required to obtain results. Qvella's innovative Field Activated Sample Treatment (FAST™) technology employs a unique electrical lysing method known as e-lysis™, allowing for the direct and fully automated rapid detection of infectious agents from unenriched biological samples. By providing actionable results in clinically relevant time frames, Qvella seeks to improve patient outcomes and transform medical practices in the field of microbiology.

Hyglos GmbH is a biotech company based in Bernried am Starnberger See, Germany, founded in 2000 and formerly known as Profos AG. The company specializes in the development of bacteriophage-derived proteins that enhance the detection and removal of harmful bacteria and their toxins, particularly Lipopolysaccharides (LPS). Hyglos utilizes principles from bacteriophage biology to create diagnostic and antimicrobial solutions, addressing challenges in endotoxin detection, demasking, and removal, as well as providing endotoxin-free products. Its product offerings include various detection kits, demasking kits, and reagents, tailored for applications in food safety testing, human diagnostics, and research. The company serves a diverse clientele, including universities, research institutes, diagnostic and biotech companies, and food safety laboratories, distributing its products globally through distributors. As of 2016, Hyglos operates as a subsidiary of bioMérieux S.A.

Applied Maths NV specializes in developing software solutions for the biosciences industry, focusing on the databasing, analysis, and interpretation of complex biological data. The company's product suite includes BioNumerics, which facilitates the analysis of 1D patterns, 2D gels, and DNA/protein sequences, and GelCompar II, designed for electrophoresis pattern comparison. Additional offerings include GeneMaths XT for microarray analysis, Kodon for integrated sequence analysis, and BioNumerics 2D for 2D gel databasing. Applied Maths also provides a range of bioinformatics applications such as multi-locus sequence typing and HIV drug resistance analysis. The company caters to a diverse clientele that includes universities, hospitals, public health institutions, and the pharmaceutical and food industries, offering services such as training workshops, on-site training, data analysis, and script development. Founded in 1992 and headquartered in Sint-Martens-Latem, Belgium, with an office in Austin, Texas, Applied Maths operates as a subsidiary of bioMérieux S.A.

Ceeram develops molecular diagnostics for the detection and identification of emerging microbial agents. Ceeram develops and manufactures ceeramTools™ Test Kits (Virus, Parasites), designed with innovative methods, offers training and consulting in the field of molecular microbiology, in Food, Environmental and Health sectors.

SARL ADVENCIS is a privately held company that manufactures lab instruments and medical devices.

BioFire Diagnostics is a clinical diagnostics company based in Salt Lake City, Utah, that focuses on detecting pathogens and mutations for molecular diagnostics. Founded in 1990, the company holds over 70 patents related to polymerase chain reaction (PCR) technology, including innovations in rapid PCR cycling. BioFire offers nearly 200 products tailored for clinical, research, and military applications. Its services are designed to provide accurate results in syndromic infectious disease diagnostics, utilizing real-time thermocycling and mutation scanning. BioFire's diagnostic panels test for a wide range of viruses, bacteria, and antimicrobial resistance genes, thereby enabling healthcare providers to assess and improve treatment outcomes for patients of all ages.

Quanterix Corporation is a life sciences company focused on developing an advanced platform for single-molecule analysis, known for its ultra-sensitive digital immunoassay technology. This innovative approach enables precise detection and quantification of individual proteins and small molecules in complex biological samples, which is critical for clinical diagnostics, drug development, and life science research. Quanterix's flagship technology, Simoa, allows for the reliable measurement of protein biomarkers in extremely low concentrations, surpassing conventional immunoassay methods. The company offers a range of products, including assay kits, specialized assays for neurodegenerative diseases, and advanced instrumentation designed to enhance early disease detection and improve patient outcomes. Founded in 2007, Quanterix is supported by prominent life science investors, positioning it to address significant unmet medical needs and contribute to advancements in healthcare.

RTS Life Sciences manufactures and provides automated products and solutions for industrial and scientific applications.

RAS Lifesciences is a manufacturer of diagnostic kits located in Muluga, India. The company specializes in the development and production of products based on molecular biology, emphasizing innovation in the field of diagnostics. By focusing on this advanced area of science, RAS Lifesciences aims to contribute to healthcare by providing reliable diagnostic solutions.

Argene is a specialising in molecular diagnostics for immunocompromised patients.

AES Laboratoire has products spanning applications for the food, pharmaceutical, and cosmetic industries. The company’s offerings include a complete portfolio of conventional and novel culture media, rapid microbiology testing methods, and laboratory instruments, as well as cytometry for the detection of microorganisms, with an innovative range of flow cytometers and a solid-phase cytometer, ChemScan RDI. The company also provides a range of services, as well as software for laboratory monitoring and metrology.

Shanghai Zenka Biotechnology is a biotechnology company.

Meikang Biotech is acompany has a wide range of rapid tests based on lateral flow immunoassay technology, including tests for infectious diseases, cardiovascular diseases and cancer. Many of these products are CE marked and some have received FDA 510k approval.

PML Microbiologicals, Inc. manufactures culture media and microbiological products for clinical and industrial applications in North America. It offers prepared culture media, stains, reagents, quality control organisms, sterility products, and collection and transport systems, as well as accessories for microbiology laboratories. The company also provides custom products, such as minimum inhibitory concentration panels, parasitology kits, diluents, and rinsing fluids. It serves clinical, pharmaceutical, research, environmental, personal care, and food and beverage industries. PML Microbiologicals, Inc. was formerly known as Prepared Media Laboratory. The company was founded in 1969 and is headquartered in Wilsonville, Oregon. It has manufacturing facilities in Mississauga, Canada; and Portland, Oregon. As of December 8, 2008, PML Microbiologicals, Inc. operates as a subsidiary of BioMérieux S.A.

AviaraDx discovers, develops, and commercializes new molecular diagnostic tests in oncology, enabling physicians to personalize cancer treatment through better understanding of the molecular biology underlying a patient’s tumor. Our tests improve the classification of cancer, support physicians to provide their patients with a more specific prognosis or individual risk assessment, and will eventually provide information critical to predict treatment response to a given therapeutic regimen. AviaraDx offers diagnostic tests to qualified physicians or laboratories through its certified CLIA and CAP laboratory service operations. The company's first two diagnostic test offerings are based on its proprietary technologies used in molecular classification of metastatic cancer (CancerTYPE ID™) and its test to assess risk of recurrence in certain breast cancer patients, (H/I™ (HOXB13/IL17BR).

AB bioMérieux is a privately held company that designs, develops, produces, and markets diagnosis systems for medical applications.

AdvanDx, Inc. is a biotechnology company based in Woburn, Massachusetts, specializing in molecular diagnostic tests for identifying pathogens responsible for critical infections in hospitalized patients. Founded in 2002, the company focuses on improving patient outcomes by facilitating earlier antibiotic therapy through rapid pathogen identification. AdvanDx offers a range of products, including QuickFISH and PNA FISH tests for detecting bacteria and yeast from positive blood cultures, as well as XpressFISH for identifying resistance markers. Its PNA Probes target ribosomal RNA sequences in bacteria and fungi. The company provides its diagnostic solutions to medical centers, reference laboratories, government institutions, and community hospitals, distributing its products through a network of sales representatives and international distributors. AdvanDx has operated as a subsidiary of OpGen, Inc. since 2015.

BTF Pty is a manufacturer and supplier of the world’s most precise quality controls for Cryptosporidium and Giardia testing, helping to deliver safe drinking water.

Biomedics is a specialized technical laboratory in elaboration of prepared culture and diagnostic media.

Bacterial Barcodes provides the equipment, reagents and software for microbial genotyping of bacteria and fungi. Packaged together, these components are referred to as the DiversiLab System.

Since 2017, MEDoctor's mission is to empower the patient to help himself determine his health problems and thereby to be routed towards the appropriate healthcare professional. The MEDoctor artificial intelligence based health assessment system won’t replace a medical visit to the doctor to have the final diagnosis and the correct treatment. But it will be useful to identify which pain, disease or illness can correspond to the symptoms you have and then make the choice of the physician to see or the treatment to follow. The MEDoctor Symptom Checker is a guide that will help you for all kinds of problems, for a benign disease as a cold or something more serious as a cancer. MEDoctor is one of the world’s most advanced symptom checkers, with its artificial intelligence and the patents to protect it. Diseases we can detect include back pain, knee pain, breast cancer, diabetes, skin cancer, heart disease, liver disease, depression, body aches, diarrhea, kidney infection, asthma, lymphoma. The list of possible disease covered is now close to 1'000. The MEDoctor Symptom Checker Version 4.1 is available “Free-of-Cost” to individuals worldwide. Individuals, family members and friends may use it as often as necessary and wherever the Internet is accessible. The system is user-friendly and works on any web-enabled device. Prior to 2017, MEDoctor had worked on and developed patient enrollment systems, such as registration at the HMO, delivery of basic health symptoms and populating of electronic health records. These systems, essentially mainframe computer based, were targeting hospitals, HMOs and IPAs and with the assistance of a healthcare professional. Since 2014, MEDoctor has taken a different route by progressively building upon its legacy systems a brand new technology, capable of running on the Cloud and suited for the patient on his smartphone. Thereafter, when the patient decides to speak to a physician, he can immediately deliver his accumulated data, symptoms and likely diseases, to facilitate the physicians diagnosis.